Showing results (1-10 of 519) with videos related to
Sort By:
Pageof 52
Expert Opinion on Investigational Drugs|May 8, 2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary L Simmons, Steven GrantLeukemia Research Reports|August 27, 2013
Mcl-1 as a Therapeutic Target in Acute Myelogenous Leukemia (AML)Prithviraj Bose, Steven GrantJournal of Clinical Medicine|June 27, 2015
Rational Combinations of Targeted Agents in AMLPrithviraj Bose, Steven GrantPharmacology & Therapeutics|April 29, 2014
Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insightsPrithviraj Bose, Yun Dai, Steven GrantPhysiological Genomics|May 15, 2014
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AMLPankit Vachhani, Prithviraj Bose, Mohamed Rahmani, et al.Expert Opinion on Pharmacotherapy|September 30, 2014
Bortezomib for the treatment of non-Hodgkin's lymphomaPrithviraj Bose, Michael S Batalo, Beata Holkova, et al.Leukemia Research Reports|August 27, 2013
Strategies to circumvent the T315I gatekeeper mutation in the Bcr-Abl tyrosine kinasePrithviraj Bose, Haeseong Park, Jawad Al-Khafaji, et al.Expert Opinion on Orphan Drugs|October 23, 2020
Advances in potential treatment options for myeloproliferative neoplasm associated myelofibrosisPrithviraj BoseClinical Lymphoma, Myeloma & Leukemia|September 1, 2020
A Young Woman with ThrombocytosisPrithviraj BoseCurrent Hematologic Malignancy Reports|March 5, 2024
Management of Patients with Early Myelofibrosis: A Discussion of Best PracticesPrithviraj BosePageof 52